Treatment of Depression in Parkinson's Disease Trial
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the effectiveness and safety of two
antidepressants--nortriptyline and paroxetine, compared to placebo in patients with
Parkinson's disease and depression.